Efficacy and safety of 28-day treatment with oral insulin (ORMD-0801) in patients with type 2 diabetes: A randomized, placebo-controlled trial.
Diabetes Obes Metab. 2021 Nov;23(11):2529-2538. doi: 10.1111/dom.14499. Epub 2021 Aug 18.
Diabetes Obes Metab. 2021.
PMID: 34310011
Clinical Trial.